Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 7 studies | 32% ± 11% | |
enterocyte | 6 studies | 52% ± 12% | |
goblet cell | 3 studies | 21% ± 5% | |
adipocyte | 3 studies | 27% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3818.83 | 226 / 226 | 100% | 49.84 | 406 / 406 |
stomach | 100% | 2838.08 | 359 / 359 | 100% | 92.17 | 286 / 286 |
uterus | 100% | 2788.92 | 170 / 170 | 100% | 42.88 | 459 / 459 |
ovary | 100% | 1982.22 | 180 / 180 | 100% | 60.18 | 429 / 430 |
intestine | 100% | 7995.59 | 966 / 966 | 100% | 97.62 | 525 / 527 |
adrenal gland | 100% | 10529.88 | 258 / 258 | 100% | 43.67 | 229 / 230 |
thymus | 100% | 2988.46 | 653 / 653 | 100% | 31.58 | 602 / 605 |
esophagus | 100% | 2872.02 | 1445 / 1445 | 99% | 43.75 | 182 / 183 |
skin | 100% | 2251.23 | 1808 / 1809 | 99% | 42.63 | 469 / 472 |
prostate | 100% | 3102.15 | 245 / 245 | 99% | 31.41 | 497 / 502 |
brain | 99% | 2344.02 | 2609 / 2642 | 100% | 30.80 | 705 / 705 |
breast | 100% | 4717.01 | 459 / 459 | 99% | 40.98 | 1104 / 1118 |
bladder | 100% | 2970.38 | 21 / 21 | 99% | 58.72 | 497 / 504 |
pancreas | 100% | 1434.24 | 327 / 328 | 99% | 49.91 | 176 / 178 |
kidney | 100% | 2850.39 | 89 / 89 | 98% | 22.41 | 887 / 901 |
lung | 100% | 3260.21 | 577 / 578 | 99% | 43.87 | 1138 / 1155 |
adipose | 100% | 5521.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 57.04 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.43 | 29 / 29 |
muscle | 100% | 2914.49 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4490.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.29 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 81.86 | 1 / 1 |
heart | 100% | 2814.84 | 859 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1925.56 | 1328 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3372.12 | 919 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006640 | Biological process | monoacylglycerol biosynthetic process |
GO_0055089 | Biological process | fatty acid homeostasis |
GO_0035336 | Biological process | long-chain fatty-acyl-CoA metabolic process |
GO_0046339 | Biological process | diacylglycerol metabolic process |
GO_0034379 | Biological process | very-low-density lipoprotein particle assembly |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0019915 | Biological process | lipid storage |
GO_0042572 | Biological process | retinol metabolic process |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003846 | Molecular function | 2-acylglycerol O-acyltransferase activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004144 | Molecular function | diacylglycerol O-acyltransferase activity |
GO_0050252 | Molecular function | retinol O-fatty-acyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DGAT1 |
Protein name | Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (EC 2.3.1.76) (Acyl-CoA retinol O-fatty-acyltransferase) (Diglyceride acyltransferase) DGAT1 protein diacylglycerol O-acyltransferase (EC 2.3.1.20) Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase) |
Synonyms | AGRP1 DGAT |
Description | FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates . Highly expressed in epithelial cells of the small intestine and its activity is essential for the absorption of dietary fats . In liver, plays a role in esterifying exogenous fatty acids to glycerol, and is required to synthesize fat for storage . Also present in female mammary glands, where it produces fat in the milk (By similarity). May be involved in VLDL (very low density lipoprotein) assembly . In contrast to DGAT2 it is not essential for survival (By similarity). Functions as the major acyl-CoA retinol acyltransferase (ARAT) in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity leading to skin and hair disorders . Exhibits additional acyltransferase activities, includin acyl CoA:monoacylglycerol acyltransferase (MGAT), wax monoester and wax diester synthases (By similarity). Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) . . |
Accessions | O75907 A0A0A0MR74 Q9BRH5 ENST00000332324.5 ENST00000528718.6 Q3KQR6 ENST00000644790.2 |